Vivos Therapeutics (VVOS) Notes Payables (2020)
Vivos Therapeutics' (VVOS) quarterly Notes Payables came in at $1.5 million in Q4 2020.
Vivos Therapeutics (VVOS) Notes Payables (2020) Analysis & Trends
Vivos Therapeutics (VVOS) has 1 years of Notes Payables data on file, last reported at $1.5 million in Q4 2020.
- On a quarterly basis, Notes Payables changed N/A year-over-year to $1.5 million in Q4 2020; TTM through Dec 2020 was $1.5 million, a N/A change from a year earlier, with the FY2020 full-year figure at $1.5 million, changed N/A from the prior year.
- Notes Payables for Q4 2020 stood at $1.5 million.
- Over the last five years, Notes Payables for VVOS reached as high as $1.5 million in Q4 2020 and fell as low as $1.5 million in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 1.50 Mn |